Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 31% ± 15% | |
peripheral blood | 12 studies | 27% ± 7% | |
intestine | 9 studies | 23% ± 11% | |
kidney | 7 studies | 30% ± 4% | |
brain | 7 studies | 21% ± 5% | |
eye | 6 studies | 27% ± 12% | |
liver | 5 studies | 32% ± 24% | |
uterus | 4 studies | 32% ± 12% | |
lymph node | 4 studies | 29% ± 12% | |
pancreas | 3 studies | 51% ± 14% | |
bone marrow | 3 studies | 19% ± 1% | |
breast | 3 studies | 24% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 4989.34 | 258 / 258 | 100% | 130.28 | 230 / 230 |
ovary | 100% | 2503.67 | 180 / 180 | 100% | 114.83 | 430 / 430 |
thymus | 100% | 3444.58 | 653 / 653 | 100% | 144.10 | 605 / 605 |
brain | 100% | 3156.82 | 2638 / 2642 | 100% | 93.03 | 705 / 705 |
uterus | 100% | 2655.55 | 170 / 170 | 100% | 76.25 | 458 / 459 |
kidney | 100% | 3652.58 | 89 / 89 | 100% | 88.72 | 898 / 901 |
liver | 100% | 1900.83 | 225 / 226 | 100% | 77.81 | 406 / 406 |
skin | 99% | 1927.92 | 1799 / 1809 | 100% | 124.46 | 472 / 472 |
intestine | 100% | 1987.46 | 966 / 966 | 99% | 83.14 | 524 / 527 |
prostate | 100% | 2773.58 | 245 / 245 | 99% | 129.27 | 499 / 502 |
pancreas | 99% | 1170.39 | 326 / 328 | 100% | 74.75 | 178 / 178 |
stomach | 100% | 1765.27 | 359 / 359 | 99% | 73.91 | 284 / 286 |
bladder | 100% | 2336.29 | 21 / 21 | 99% | 86.23 | 500 / 504 |
breast | 100% | 2923.03 | 459 / 459 | 99% | 87.07 | 1108 / 1118 |
esophagus | 100% | 2153.04 | 1445 / 1445 | 99% | 44.32 | 181 / 183 |
lung | 100% | 2508.00 | 576 / 578 | 99% | 64.14 | 1141 / 1155 |
adipose | 100% | 2900.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 124.97 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 104.31 | 29 / 29 |
spleen | 100% | 2447.13 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 56.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 86.99 | 1 / 1 |
heart | 100% | 4258.49 | 858 / 861 | 0% | 0 | 0 / 0 |
muscle | 100% | 3148.81 | 800 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2290.70 | 1330 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 2074.94 | 915 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032981 | Biological process | mitochondrial respiratory chain complex I assembly |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | NDUFAF3 |
Protein name | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 |
Synonyms | C3orf60 |
Description | FUNCTION: Essential factor for the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I). . |
Accessions | ENST00000326925.11 [Q9BU61-1] Q9BU61 ENST00000326912.8 [Q9BU61-2] ENST00000395458.6 [Q9BU61-2] ENST00000451378.2 [Q9BU61-2] |